4C Biomed
Unlocking the Promise of Immune Checkpoint Inhibitors
Startup4C Biomed is a Netanya-based startup in the Health Tech & Life Sciences sector, established in 2016. Unlocking the Promise of Immune Checkpoint Inhibitors. 4C Biomed was founded by Eyal Greenberg and Gal Markel. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQNetanya
- DistrictCenter District
- Last RoundUndisclosed
Eyal GreenbergCo-founder & CEO
Gal MarkelCo-founder & CSO
What does 4C Biomed do?
4C Biomed combines cutting-edge science, real-world clinical insights and unique autologous cell systems (i.e. cancer and immune cells from the same patient) to drive the development of immuno-oncology therapies. Its lead drug is in a stage of IND-enabling studies and is planned to enter clinical Phase I in 2025. 4C Biomed’s technology leverages a uniquely sensitive, immunological-based screening platform, which not only identifies novel immuno-oncology targets but also promises to accelerate the journey from discovery to clinical application.
Who founded 4C Biomed?
4C Biomed was founded in 2016 by Eyal Greenberg (Co-founder & CEO), Gal Markel (Co-founder & CSO).
What sector is 4C Biomed in?
4C Biomed operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is 4C Biomed located?
4C Biomed is based in Ha-Melakha St 5, Netanya, Israel, Center District. The company also has offices abroad.